Abstract
Specific heterodimerization and DNA binding by the b-HLH-LZ transcription factors c-Myc and Max is central to the activation and repression activities of c-Myc that lead to cell growth, proliferation, and tumorigenesis (Adhikary and Eilers, Nat Rev Mol Cell Biol 6:635–645, 2005; Eilers and Eisenman, Genes Dev 22:2755–2766, 2008; Grandori et al., Annu Rev Cell Dev Biol 16:653–699, 2000; Whitfield and Soucek, Cell Mol Life Sci 69:931–934, 2011). Although many c-Myc-interacting partner proteins are known to interact through their HLH domain (Adhikary and Eilers, Nat Rev Mol Cell Biol 6:635–645, 2005), current knowledge regarding the structure and the determinants of molecular recognition of these complexes is still very limited. Moreover, recent advances in the development and use of b-HLH-LZ dominant negatives (Soucek et al., Nature 455:679–683, 2008) and inhibitors of c-Myc interaction with its protein partners (Bidwell et al., J Control Release 135:2–10, 2009; Mustata et al., J Med Chem 52:1247–1250, 2009; Prochownik and Vogt, Genes Cancer 1:650–659, 2010) or DNA highlight the importance of efficient protocols to prepare such constructs and variants. Here, we provide methods to produce and purify high quantities of pure and untagged b-HLH-LZ constructs of c-Myc and Max as well as specific c-Myc/Max heterodimers for their biophysical and structural characterization by CD, NMR, or crystallography. Moreover, biochemical methods to analyze the homodimers and heterodimers as well as DNA binding of these constructs by native electrophoresis are presented. In addition to enable the investigation of the c-Myc/Max b-HLH-LZ complexes, the protocols described herein can be applied to the biochemical characterization of various mutants of either partner, as well as to ternary complexes with other partner proteins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635–645
Eilers M, Eisenman RN (2008) Myc's broad reach. Genes Dev 22:2755–2766
Grandori C et al (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16:653–699
Whitfield JR, Soucek L (2012) Tumor microenvironment: becoming sick of Myc. Cell Mol Life Sci 69:931–934
Soucek L et al (2008) Modelling Myc inhibition as a cancer therapy. Nature 455:679–683
Bidwell GL et al (2009) Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. J Control Release 135:2–10
Mustata G et al (2009) Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model. J Med Chem 52:1247–1250
Prochownik EV, Vogt PK (2010) Therapeutic targeting of Myc. Genes Cancer 1:650–659
Beaulieu M-E, Mc Duff F-O, Frappier V, Montagne M, Naud J-F, Lavigne P (2012) J Mol Recognit 25:414–426. doi: 10.1002/jmr.2203
Lebel R et al (2007) Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter. Biochemistry 46:10279–10286
Mcduff F-O et al (2009) The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis. J Mol Recognit 22:261–269
Montagne M et al (2012) The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities. PLoS One 7:e32172
Naud J-F et al (2003) Improving the thermodynamic stability of the leucine zipper of max increases the stability of its b-HLH-LZ:E-box complex. J Mol Biol 326:1577–1595
Sauvé S et al (2007) The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors. J Mol Biol 365:1163–1175
Sauvé S et al (2004) The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors. J Mol Biol 342:813–832
Tam JPWCRLWZJW (1991) Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications. J Am Chem Soc 113:6657–6662
Chrambach A, Jovin T (1983) Selected buffer systems for moving boundary electrophoresis on gels at various pH values, presented in a simplified manner. Electrophoresis 4:190–204
Garner MM, Revzin A (1981) A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res 9:3047–3060
Fried M, Crothers DM (1981) Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9:6505–6525
Sambrook J, F. EF, Maniatis T (1989) Molecular cloning, a laboratory manual, 2nd edn. Cold Spring Harbor, New York
Larouche K et al (1996) Optimization of competitor poly(dI-dC).poly(dI-dC) levels is advised in DNA-protein interaction studies involving enriched nuclear proteins. Biotechniques 20:439–444
Fried MG (1989) Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay. Electrophoresis 10:366–376
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Beaulieu, ME., McDuff, FO., Bédard, M., Montagne, M., Lavigne, P. (2013). Methods for the Expression, Purification, Preparation, and Biophysical Characterization of Constructs of the c-Myc and Max b-HLH-LZs. In: Soucek, L., Sodir, N. (eds) The Myc Gene. Methods in Molecular Biology, vol 1012. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-429-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-429-6_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-428-9
Online ISBN: 978-1-62703-429-6
eBook Packages: Springer Protocols